促销时间表 Neoleukin Therapeutics, Inc.
先进的时间表
简单图表
关于公司
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. 更多详情| Выручка | 0.025 |
|---|---|
| EBITDA | -0.0315 |
| Число акций ао | 0.05522 млрд |
| P/S | 45.72 |
| P/BV | 15.73 |
| EV/EBITDA | -33.84 |
| Цена ао | 15.1 |
| ISIN | US64049K1043 |
| Сайт | https://www.neoleukin.com |
| Валюта | usd |
| IPO date | 2014-03-07 |
| Sector | Health Care |
| Industry | Biotechnology |
| Валюта отчета | usd |
| 每日价格变化: | 0% (15.1) |
|---|---|
| 每周价格变化: | 0% (15.1) |
| 每月价格变化: | 0% (15.1) |
| 3个月内价格变化: | 0% (15.1) |
| 六个月内的价格变化: | 0% (15.1) |
| 每年价格变化: | +274.69% (4.03) |
| 3年内价格变化: | +87.34% (8.06) |
| 5年内价格变化: | +318.28% (3.61) |
| 年初以来价格变化: | +345.43% (3.39) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| Baker Brothers Advisors, LLC | 1221414 | 13 |
| Redmile Group, LLC | 582443 | 6.2 |
| Adage Capital Partners GP L.L.C. | 310000 | 3.3 |
| Nantahala Capital Management, LLC | 299999 | 3.19 |
| Bank of America Corporation | 231779 | 2.47 |
| Vanguard Group Inc | 201539 | 2.14 |
| Renaissance Technologies, LLC | 163447 | 1.74 |
| Morgan Stanley | 107671 | 1.15 |
| Bml Capital Management, LLC | 98664 | 1.05 |
| Blackrock Inc. | 96613 | 1.03 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Ms. Donna M. Cochener-Metcalfe J.D. | Gen. Counsel & Sr. VP of Legal | 403.75k | 1975 (49 年) |
| Mr. Sean Michael Smith | Principal Accounting Officer, VP of Fin. & Controller | N/A | 1986 (38 年) |
| Dr. Jonathan G. Drachman M.D. | CEO, Pres, Principal Financial Officer & Director | 1962 (62 年) | |
| Dr. Priti Patel M.D., M.S. | Chief Medical Officer | 1976 (48 年) | |
| Dr. David Baker | Co-founder & Member of Scientific Advisory Board | ||
| Dr. Carl Walkey Ph.D. | Sr. VP of Corp. Devel. | 1985 (39 年) | |
| Mr. Kamran Alam | Sr. Strategic Advisor | 1974 (50 年) | |
| Dr. Bill Arthur | VP & Head of Research | ||
| Mr. Umut Ulge | VP of Clinical Devel. |
地址: United States, Seattle. WA, 188 East Blaine Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.neoleukin.com
网站: https://www.neoleukin.com
